Compare ACCO & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACCO | SMTI |
|---|---|---|
| Founded | 1893 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.3M | 313.5M |
| IPO Year | 2005 | 2008 |
| Metric | ACCO | SMTI |
|---|---|---|
| Price | $4.24 | $34.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 594.6K | 296.6K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 9.26% | N/A |
| EPS Growth | ★ 141.51 | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $1,524,700,000.00 | $15,586,976.00 |
| Revenue This Year | $3.10 | $17.31 |
| Revenue Next Year | $0.89 | $12.48 |
| P/E Ratio | $12.11 | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $2.81 | $16.05 |
| 52 Week High | $4.56 | $35.53 |
| Indicator | ACCO | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 49.93 | 76.23 |
| Support Level | $4.22 | $33.99 |
| Resistance Level | $4.31 | N/A |
| Average True Range (ATR) | 0.11 | 0.26 |
| MACD | -0.01 | -0.25 |
| Stochastic Oscillator | 48.57 | 80.43 |
ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.